attr cm heart disease

Meet Raymond and Alan, two people diagnosed with transthyretin cardiac amyloidosis (ATTR-CM), a rare and underdiagnosed cause of heart failure. 1 Both led active, healthy lives before experiencing ... Benzinga.com: FDA Approves BridgeBio Pharma's Drug For Rare Heart Disease, Poised To Challenge Pfizer In Lucrative Yet Competitive Market FDA Approves BridgeBio Pharma's Drug For Rare Heart Disease, Poised To Challenge Pfizer In Lucrative Yet Competitive Market The American Journal of Managed Care: Outpatient Worsening Heart Failure Predicts Mortality in Patients With ATTR-CM ATTR-CM is a devastating, rapidly progressive, and ultimately fatal disease estimated to affect approximately 150,000 people in the U.S.

Understanding the Context

and over 300,000 people worldwide. There is no cure for ATTR-CM ... MedPage Today: ATTR Trial's Safety Freeze; Heart Failure After Twins; Sotatercept Approval Expands Although there is no cure for ATTR-CM, the U.S. Food and Drug Administration has approved three medications for treatment, with other promising medications in the pipeline.